Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT Maja Agung Latexindo TbkISX:SURI +4.00%53 OCF Margin % is 110.63% as of Jun. 2026, which is 3202% above its 10-year median of 3.35. GuruFocus rates ISX:SURI with a GF Score™ of 53/100 and a GF Value™ of Rp107.19 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 815 Medical Devices & Instruments companies, PT Maja Agung Latexindo Tbk ranks better than 94.97% on this metric.
The historical rank and industry rank for PT Maja Agung Latexindo Tbk's OCF Margin % or its related term are showing as below:
ISX:SURI'
s OCF Margin % Range Over the Past 10 Years
Min: -114.37 Med: 3.35 Max: 7.52
Current: 32.56
During the past 6 years, the highest OCF Margin % of PT Maja Agung Latexindo Tbk was 7.52%. The lowest was -114.37%. And the median was 3.35%.
ISX:SURI's OCF Margin % is ranked better than 94.97% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: 5.57
vs ISX:SURI: 32.56
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ISX:SURI vs ISRG, BDX, MDLN: OCF Margin % Comparison
For the Medical Instruments & Supplies subindustry, PT Maja Agung Latexindo Tbk's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Maja Agung Latexindo Tbk OCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, PT Maja Agung Latexindo Tbk's OCF Margin % distribution charts can be found below:
* The bar in red indicates where PT Maja Agung Latexindo Tbk's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Maja Agung Latexindo Tbk (ISX:SURI) has a OCF Margin % of 110.63% as of Jun. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on PT Maja Agung Latexindo Tbk and its competitors. This is 3202% above median its historical median of 3.35. According to the industry distribution chart, PT Maja Agung Latexindo Tbk ranks #41 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 5%.
Is PT Maja Agung Latexindo Tbk's OCF Margin % too high?
PT Maja Agung Latexindo Tbk's current OCF Margin % of 110.63% is 3202% above median its 10-year median of 3.35. The Medical Devices & Instruments industry median OCF Margin % is 5.57. PT Maja Agung Latexindo Tbk's value of 110.63% is 1886.2% above this industry median. Based on the distribution chart, PT Maja Agung Latexindo Tbk ranks #41 out of 815 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, PT Maja Agung Latexindo Tbk has a GF Score™ of 53/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Maja Agung Latexindo Tbk's OCF Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, PT Maja Agung Latexindo Tbk ranks #41 out of 815 companies for OCF Margin %. This places PT Maja Agung Latexindo Tbk in the top 5% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 5.57. PT Maja Agung Latexindo Tbk's value of 110.63% is 1886.2% above this benchmark. While the company's 10-year median is 3.35 vs. the industry median of 5.57, PT Maja Agung Latexindo Tbk has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.57, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Maja Agung Latexindo Tbk's current OCF Margin % of 110.63% is 1886.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on PT Maja Agung Latexindo Tbk and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Maja Agung Latexindo Tbk's current OCF Margin % is 110.63%, which is 3202% above median its own 10-year median of 3.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Maja Agung Latexindo Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Maja Agung Latexindo Tbk (ISX:SURI) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp107.19, compared to a current price of Rp78.00 — trading 27.2% below its estimated fair value. The current OCF Margin % is 110.63%, which is 3202% above median its 10-year median of 3.35 and 1886.2% above the Medical Devices & Instruments industry median of 5.57. PT Maja Agung Latexindo Tbk's overall GF Score™ is 53/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For PT Maja Agung Latexindo Tbk (ISX:SURI), the current OCF Margin % is 110.63% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Maja Agung Latexindo Tbk (ISX:SURI) Overvalued in 2026?
Based on GuruFocus' analysis, PT Maja Agung Latexindo Tbk stock appears to be undervalued.
The current stock price of Rp78.00 is trading 27.2% below its estimated GF Value™ of Rp107.19.
GuruFocus considers PT Maja Agung Latexindo Tbk to be Modestly Undervalued.
Key valuation signals for ISX:SURI:
OCF Margin %: 110.63% (3202% above median its 10-year median of 3.35)
GF Value™: Rp107.19 vs. price of Rp78.00 (27.2% below fair value)
Industry Position: 1886.2% above the Medical Devices & Instruments median (#41 of 815)
No single metric tells the full story. See the ISX:SURI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Maja Agung Latexindo Tbk specializes in the production of latex gloves, made from natural rubber, and is a primary choice in the medical and industrial sectors. The company's business includes business of making rubber goods for health support needs, such as contraceptive gloves (birth control)/ condoms, pacifiers and compresses, medical rubber gloves, and urinary catheters (folley catheter). Its segments include Gloves and Concentrated latex.
53GF Score
Get the complete analysis for ISX:SURI
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:SURI has been successfully added to your 
